Nanovaccines co-delivering antigen and dual TLR agonists potentiate aged immunity by orchestrating TCR repertoire
Journal of Controlled Release · 2026
DOI: 10.1016/j.jconrel.2026.115262 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2026. Verfasst von Haolin Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Materials Science and Engineering, Key Laboratory for Polymeric Composite and Functional Materials of Ministry of Education, Sun Yat-Sen Un…. Hauptthemen laut MEDLINE: Toll-Like Receptor Agonists, Nanovaccines, Lipid A, Receptors, Antigen, T-Cell. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Science and Technology Major Project, National Major Science and Technology Projects of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Immunosenescence increases susceptibility to varicella-zoster virus (VZV) infection in the elderly while compromising vaccine responsiveness. Although clinical adjuvants such as AS01 have improved vaccine efficacy, challenges associated with saponin-based components and separate antigen-adjuvant formulations persist. Here, we developed a nanovaccine, NP(gEIM), that co-encapsulates VZV glycoprotein E (gE) with the TLR4 agonist MPLA and TLR7/8 agonist IMQ in lipid nanoparticles via flash nanocomplexation (FNC), enabling coordinated co-delivery of antigen and adjuvants. NP(gEIM) efficiently targeted draining lymph nodes and promoted antigen-presenting cell uptake and maturation. In young and aged mice, NP(gEIM) elicited gE-specific antibody responses and Th1-biased cellular immunity comparable to AS01-adjuvanted gE vaccines while exceeding aluminum-adjuvanted vaccines. Moreover, NP(gEIM) enhanced IFN-γ and TNF-α production by antigen-specific CD4+ and CD8+ T cells while reducing immunosuppressive Treg and MDSC populations in aged mice. Notably, NP(gEIM) reshaped the TCR repertoire by promoting selective expansion of putative antigen-responsive T cell clones and altering TCR V/J gene usage and CDR3 length distribution, providing molecular insights into vaccine-induced T cell responses. Collectively, this study presents a nanovaccine strategy enabling coordinated delivery of antigen and dual TLR agonists. By integrating humoral and cellular immunity with TCR repertoire modulation, NP(gEIM) offers a potential strategy for improving vaccine responses in aging populations and developing vaccines against age-associated infectious diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Materials Science and Engineering, Key Laboratory for Polymeric Composite and Functional Materials of Ministry of Education, Sun Yat-Sen University, Guangzhou 510275, China.
- Sinovac Biotech Co. Ltd, No. 39 Shangdi Xi Road, Beijing 100085, China.
- Translational Medical Center of Huaihe Hospital, Henan University, Kaifeng, Henan 475004, China; State Key Laboratory of Antiviral Drugs, Henan University, Zhengzhou, Henan 450046, China. Electronic address: liuhong@hen…
- School of Materials Science and Engineering, Key Laboratory for Polymeric Composite and Functional Materials of Ministry of Education, Sun Yat-Sen University, Guangzhou 510275, China; Guangxi Academy of Medical Sciences…
- School of Materials Science and Engineering, Key Laboratory for Polymeric Composite and Functional Materials of Ministry of Education, Sun Yat-Sen University, Guangzhou 510275, China; College of Chemistry and Molecular…
Förderung
- National Science and Technology Major Project
- National Major Science and Technology Projects of China
- National Natural Science Foundation of China
Zitieren
APA
Chen, H., Zhang, Z., Wen, Z., Yang, Z., Li, L., Wang, S., Gao, Q., Liu, H., Liu, L., & Chen, Y. (2026). Nanovaccines co-delivering antigen and dual TLR agonists potentiate aged immunity by orchestrating TCR repertoire. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2026.115262
Vancouver
Chen H, Zhang Z, Wen Z, Yang Z, Li L, Wang S, et al. Nanovaccines co-delivering antigen and dual TLR agonists potentiate aged immunity by orchestrating TCR repertoire. Journal of Controlled Release. 2026. doi:10.1016/j.jconrel.2026.115262
BibTeX
@article{Chen2026,
author = {Chen, Haolin and Zhang, Zhihui and Wen, Zhenfu and Yang, Zeyu and Li, Liyan and Wang, Sheng and Gao, Qiang and Liu, Hong and Liu, Lixin and Chen, Yongming},
title = {Nanovaccines co-delivering antigen and dual TLR agonists potentiate aged immunity by orchestrating TCR repertoire},
journal = {Journal of Controlled Release},
year = {2026},
doi = {10.1016/j.jconrel.2026.115262}
}
EUVIMED